Ropharma SA earns net profit by 50% higher in H1

0
 
Ropharma SA pharmaceuticals distributor of Brasov (central), scored a net profit worth 221,509 lei in the first half of the year, by 50% higher than that made during the same period of 2007, Company data say.
Ropharma's turnover exceeded 389.3 million lei during the above said period, by 38% more than that in 2007.
 
The growth is by 22% over the level of the pharmaceuticals market's growth given that the retail market is by 16% bigger.
"The increase in the profitability is mainly owed to the rise in the turnover, the number of clients and the steps taken through the indirect costs control, said Ropharma SA manager Alin Radasanu.
 
The Company's investments amounted to about 200,000 euros, in the first half of the year, and were directed to the rehabilitation of its pharmacies and the partial replacement of the distribution fleet, which also represent engines to profitability rise.Investments will continue in the second half of the year on money coming from the increase in the Company's share capital by 750,000 euros, an increase the National Securities Commission (CNVM) okayed late in March 2008, Company's official said.
 
Brasov-based Ropharma pharmaceuticals distributor prepares to merger by absorption with companies such as Farmaceuitica Aesculap, Medica Bacau (east) and Global Pharmaceuticals Brasov. Ropaharma SA is traded on the Rasdaq market of the Bucharest Stock Exchange (BVB) and it concluded BVB's Aug. 28 session at 0.59 lei.
Citește și

Spune ce crezi

Adresa de email nu va fi publicata

Acest sit folosește Akismet pentru a reduce spamul. Află cum sunt procesate datele comentariilor tale.